Brain neprilysin activity and susceptibility to transgene-induced Alzheimer amyloidosis

被引:23
作者
Carter, TL
Pedrini, S
Ghiso, J
Ehrlich, ME
Gandy, S
机构
[1] Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA
[4] Lankenau Inst Med Res, Wynnewood, PA 19096 USA
[5] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA
关键词
Alzheimer; amyloid degradation; neprilysin;
D O I
10.1016/j.neulet.2005.09.022
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neprilysin (NEP) is a zinc metalloproteinase that degrades enkephalins, endothelins, and the Alzheimer's disease amyloid beta(A beta) peptides. NEP-deficient mice possess increased levels of brain A beta(1-40) and A beta(1-42). The objective of this study was to determine whether tissue NEP specific activity differs according to age and/oracross mouse strains, especially those strains predisposed toward formation of A beta-amyloid plaques following overexpression of the human Alzheimer amyloid precursor protein (APP). The C57131/6J mouse strain appears to be relatively susceptible to cerebral amyloidosis, whereas the Swiss Webster (SW) strain appears more resistant. We investigated whether NEP specific activity in brain and kidney homogenates from SW and C57 mice of 6, 40, and 80 weeks old varied according to mouse strain, age, and gender. Among the variables tested, NEP specific activity varied most dramatically across mouse strain, with the kidney and brain of SW mice displaying the highest activities. Aging was associated with a reduction in brain NEP specific activity in both strains. Gender-specific differences were identified in kidney but not in brain. We conclude that aging- and strain-dependent differences in NEP specific activity may play a role in the differential susceptibility of some mouse strains for developing cerebral amyloidosis following human APP overexpression. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:235 / 239
页数:5
相关论文
共 33 条
[1]  
Alzheimer A, 1995, Clin Anat, V8, P429
[2]   Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins [J].
Borchelt, DR ;
Ratovitski, T ;
vanLare, J ;
Lee, MK ;
Gonzales, V ;
Jenkins, NA ;
Copeland, NG ;
Price, DL ;
Sisodia, SS .
NEURON, 1997, 19 (04) :939-945
[3]   Age- and region-dependent alterations in Aβ-degrading enzymes:: implications for Aβ-induced disorders [J].
Caccamo, A ;
Oddo, S ;
Sugarman, MC ;
Akbari, Y ;
LaFerla, FA .
NEUROBIOLOGY OF AGING, 2005, 26 (05) :645-654
[4]   Augmented senile plaque load in aged female β-amyloid precursor protein-transgenic mice [J].
Callahan, MJ ;
Lipinski, WJ ;
Bian, F ;
Durham, RA ;
Pack, A ;
Walker, LC .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (03) :1173-1177
[5]   Hypoxia decreases lung neprilysin expression and increases pulmonary vascular leak [J].
Carpenter, TC ;
Stenmark, KR .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2001, 281 (04) :L941-L948
[6]   A highly selective assay for neutral endopeptidase based on the cleavage of a fluorogenic substrate related to Leu-enkephalin [J].
Carvalho, KM ;
Boileau, G ;
Camargo, ACM ;
Juliano, L .
ANALYTICAL BIOCHEMISTRY, 1996, 237 (02) :167-173
[7]   Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease [J].
DeMattos, RB ;
Bales, KR ;
Cummins, DJ ;
Dodart, JC ;
Paul, SM ;
Holtzman, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (15) :8850-8855
[8]   A HIGHLY SENSITIVE FLUOROMETRIC ASSAY FOR ENKEPHALINASE, A NEUTRAL METALLOENDOPEPTIDASE THAT RELEASES TYROSINE-GLYCINE-GLYCINE FROM ENKEPHALINS [J].
FLORENTIN, D ;
SASSI, A ;
ROQUES, BP .
ANALYTICAL BIOCHEMISTRY, 1984, 141 (01) :62-69
[9]   The role of cerebral amyloid β accumulation in common forms of Alzheimer disease [J].
Gandy, S .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (05) :1121-1129
[10]  
GhersiEgea JF, 1996, J NEUROCHEM, V67, P880